Fibroid drug relugolix may act as a contraceptive
According to research presented at the American Society for Reproductive Medicine (ASRM) 2026 meeting, relugolix (Orgovyx) — used in combination with estradiol and norethindrone acetate to…

According to research presented at the American Society for Reproductive Medicine (ASRM) 2026 meeting, relugolix (Orgovyx) — used in combination with estradiol and norethindrone acetate to manage symptoms of uterine fibroids and endometriosis — may also have a contraceptive effect.
In the phase 3, single-arm, open-label SERENE trial, Dr. Andrea Lukes, MHSc, founder and CEO of the Carolina Women’s Research and Wellness Center in Durham, North Carolina, noted that relugolix CT is approved to manage heavy menstrual bleeding caused by uterine fibroids and moderate to severe endometriosis pain. The drug, a gonadotropin-releasing hormone antagonist, suppresses the secretion of luteinizing hormone and follicle-stimulating hormone and reduces ovarian production of estradiol and progesterone.
Source: Medscape
This article is for educational and informational purposes only and is not a substitute for advice, diagnosis or treatment by a physician or pharmacist.
Original Persian text: meshcutpharmed.com
Related posts

UK regulator bans stem-cell treatment ads as “misleading”
The UK advertising watchdog has banned ads from four companies promoting stem-cell treatment for autism in children, ruling them misleading.
Read more
Is heart damage from anabolic steroids reversible?
According to a longitudinal study with 6 to 8 years of follow-up, long-term use of anabolic-androgenic steroids (AAS) in male strength athletes is associated with persistent cardiac…
Read more
Naronapride eases gastroparesis symptoms in phase 2 trial
In a phase 2b trial, naronapride — an investigational dual-action prokinetic given at 20 or 40 mg three times daily for 12 weeks — led to significantly greater improvement in core symptoms…
Read more